Elizabeth Donegan, MD; Michael P. Busch, MD, PhD; Janice A. Galleshaw, MD; George M. Shaw, MD, PhD; James W. Mosley, MD; Transfusion Safety Study Group*
Human T-lymphotropic virus type I (HTLV-I) is an etiologic agent of adult T-cell leukemia and of spastic myelopathy. Type II virus (HTLV-II) has been recovered from three patients with hairy cell leukemia and from one with exfoliative erythroderma (1-3), but the lack of evidence that HTLV-II infection is associated with other diseases is not necessarily meaningful because generally available serologic tests do not distinguish between HTLV-I and HTLV-II (4). The knowledge that HTLV-I can be transmitted by transfusion (5) prompted routine blood-donor screening in the United States and notification of past recipients of blood from positive donors (6, 7).
Learn more about subscription options.
Register Now for a free account.
Donegan E, Busch MP, Galleshaw JA, Shaw GM, Mosley JW, Transfusion Safety Study Group*. Transfusion of Blood Components from a Donor with Human T-Lymphotropic Virus Type II (HTLV-II) Infection. Ann Intern Med. 1990;113:555-556. doi: 10.7326/0003-4819-113-7-555
Download citation file:
Published: Ann Intern Med. 1990;113(7):555-556.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only